NanoVibronix, Inc. (NASDAQ:NAOV) Short Interest Update

NanoVibronix, Inc. (NASDAQ:NAOV) saw a significant increase in short interest during the month of October. As of October 15th, there was short interest totalling 515,200 shares, an increase of 3,311.9% from the September 30th total of 15,100 shares. Approximately 18.7% of the shares of the stock are short sold. Based on an average daily trading volume, of 121,900 shares, the short-interest ratio is currently 4.2 days.

NanoVibronix Stock Up 5.0 %

NanoVibronix stock traded up $0.03 during midday trading on Friday, reaching $0.55. 91,001 shares of the stock traded hands, compared to its average volume of 82,782. The stock’s fifty day moving average is $0.60 and its 200-day moving average is $0.69. NanoVibronix has a 12 month low of $0.46 and a 12 month high of $1.55. The stock has a market cap of $1.52 million, a P/E ratio of -0.42 and a beta of 1.50.

NanoVibronix (NASDAQ:NAOV) last issued its quarterly earnings data on Wednesday, August 14th. The company reported ($0.25) earnings per share (EPS) for the quarter. NanoVibronix had a negative net margin of 83.49% and a negative return on equity of 74.98%. The company had revenue of $0.82 million for the quarter.

About NanoVibronix

NanoVibronix, Inc, through its subsidiary, NanoVibronix Ltd., focuses on the manufacture and sale of noninvasive biological response-activating devices that target biofilm prevention, wound healing, and pain therapy. Its product portfolio includes UroShield, an ultrasound-based product to prevent bacterial colonization and biofilm in urinary catheters, enhance antibiotic efficacy, and decrease pain and discomfort associated with urinary catheter use.